ELV — Elevance Health Inc.

Elevance Health Q4 2025 Earnings Call Summary

1. Key Financial Results and Metrics

• Adjusted Diluted EPS: $3.33 for Q4 and $30.29 for the full year.
• Operating Revenue: $49.3 billion for Q4, up 10% year-over-year, driven by premium rate adjustments and acquisitions.
• Membership: 45.2 million members, a decrease of approximately 500,000 year-over-year, primarily due to Medicaid membership losses.
• Consolidated Benefit Expense Ratio: 93.5% for Q4 and 90% for the full year.
• Operating Cash Flow: $4.3 billion for the year, with expectations of at least $5.5 billion in 2026.
• Share Repurchases: $2.6 billion in 2025, with plans for $2.3 billion in 2026.

2. Strategic Updates and Business Highlights

• Focus on Affordability: Elevance is prioritizing improving healthcare affordability and simplifying care navigation.
• Medicaid Strategy: Working with state partners to address elevated acuity and utilization, anticipating a negative operating margin of approximately -1.75% in 2026.
• Medicare Advantage: Expecting membership to decline in the high teens percentage range, but aiming for margin improvement.
• Commercial Business: Healthy momentum in national accounts, with a disciplined pricing strategy and successful selling season.
• Carillon Services: Recognized for managing high-cost healthcare areas, though growth will be moderated by lower health plan membership.

3. Forward Guidance and Outlook

• 2026 Adjusted Diluted EPS Guidance: At least $25.50, reflecting prudent assumptions and a focus on operational execution.
• Revenue Expectations: Anticipated decline in operating revenue in the low single-digit percent range, driven by a decline in risk-based membership.
• Long-term Growth: Reaffirming a long-term algorithm of at least 12% adjusted EPS growth annually starting in 2027.

4. Bad News, Challenges, or Points of Concern

• Membership Declines: Significant losses in Medicaid and Medicare Advantage memberships due to strategic pricing decisions and eligibility reverification.
• Cost Trends: Elevated medical cost trends expected to persist, particularly in Medicaid, which could pressure margins.
• Regulatory Risks: Concerns regarding the sustainability of Medicare Advantage funding and potential impacts from risk adjustment changes.
• Margin Compression: Adjusted long-term margin targets across segments to reflect current business mix and operating environment.

5. Notable Q&A Insights

• Cost Trends: Management indicated that while cost trends are expected to moderate, they will remain elevated compared to historical norms, especially in Medicaid.
• Membership Strategy: The decline in Medicare membership was a strategic decision to exit less profitable products, aligning with long-term margin objectives.
• Carillon Services: Growth in external sales is expected to offset some internal membership declines, with a focus on risk-based solutions.
• Capital Deployment: Emphasis on maintaining a strong balance sheet and prioritizing share repurchases over new M&A activity in 2026.

Overall, Elevance Health is navigating a challenging environment with a focus on disciplined execution and strategic repositioning to enhance long-term growth and profitability.